SCHEMBL30305451

SCHEMBL30305451

O=C(Nc1cc(-c2ccc3ncnn3c2)cc2c1[C@@H](c1cc(F)ccc1Cl)NC2=O)c1cc(F)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.36
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 3/20 0.34
SLC6A3 Q01959 3/20 0.34
CSF1R P07333 1/20 0.34
AURKA O14965 1/20 0.34
WDR5 P61964 1/20 0.34
JAK2 O60674 3/20 0.33
PIK3CA P42336 2/20 0.33
ACLY P53396 1/20 0.32
TNIK Q9UKE5 1/20 0.32
TGFBR1 P36897 1/20 0.31
SRC P12931 1/20 0.31
ADCY8 P40145 1/20 0.31
ADCY1 Q08828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30305561 1.00 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL23984567 1.00 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL30305516 1.00 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL30305562 1.00 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL23985000 1.00 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL23984566 1.00 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL23984644 0.95 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL23984643 0.95 KDR (0.36) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL23985535 0.93 SLC6A2 (0.35) KDRSLC6A2SLC6A4SLC6A3CSF1R
SCHEMBL23984668 0.92 BRAF (0.39) KDRCSF1RJAK2ADCY8ADCY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116261562-A PI 3K-alpha inhibitors and methods of use thereof 传达治疗有限公司 2023-06-13 CN disclosed
EP-4143196-A1 PI3K-a INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2023-03-08 EP disclosed